Transarterial Chemoembolization Combined with Apatinib for Treatment of Advanced Hepatocellular Carcinoma: Analysis of Survival and Prognostic Factors

被引：0
|
作者：
Zi-yi Liu
Xue-feng Kan
Li-jie Zhang
Joyman Makamure
Qing Li
Dan Zhao
Guo-feng Zhou
Gan-sheng Feng
Chuan-sheng Zheng
Bin Liang
机构：
[1] Huazhong University of Science and Technology,Department of Radiology, Union Hospital, Tongji Medical College
[2] Hubei Province Key Laboratory of Molecular Imaging,undefined
来源：
Current Medical Science | 2022年 / 42卷
关键词：
chemoembolization; therapeutic; apatinib; molecular targeted therapy; survival; factor analysis; statistical;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1015 / 1021
页数：6
相关论文
共 50 条
  • [1] Transarterial Chemoembolization Combined with Apatinib for Treatment of Advanced Hepatocellular Carcinoma: Analysis of Survival and Prognostic Factors
    Liu, Zi-Yi
    Kan, Xue-Feng
    Zhang, Li-Jie
    Makamure, Joyman
    Li, Qing
    Zhao, Dan
    Zhou, Guo-Feng
    Feng, Gan-Sheng
    Zheng, Chuan-Sheng
    Liang, Bin
    CURRENT MEDICAL SCIENCE, 2022, 42 (05) : 1015 - 1021
  • [2] Transarterial Chemoembolization Combined With Apatinib for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis
    Kan, Xuefeng
    Liang, Bin
    Zhou, Guofeng
    Xiong, Bin
    Pan, Feng
    Ren, Yanqiao
    Cao, Yanyan
    Wang, Jihua
    Yang, Fan
    Zheng, Chuansheng
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [3] Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma
    Ni, Jia-Yan
    Sun, Hong-Liang
    Chen, Yao-Ting
    Luo, Jiang-Hong
    Chen, Dong
    Jiang, Xiong-Ying
    Xu, Lin-Feng
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (46) : 17483 - 17490
  • [4] The Efficacy of Transarterial Chemoembolization plus Apatinib or Sorafenib in the Treatment of Advanced Hepatocellular Carcinoma
    Chen, Lei
    Sun, Tao
    Wu, Linxia
    Zhang, Weihua
    Ren, Yanqiao
    Xiang, Dongqiao
    Liang, Bin
    Zheng, Chuansheng
    JOURNAL OF ONCOLOGY, 2021, 2021
  • [5] Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma
    Jia-Yan Ni
    Hong-Liang Sun
    Yao-Ting Chen
    Jiang-Hong Luo
    Dong Chen
    Xiong-Ying Jiang
    Lin-Feng Xu
    World Journal of Gastroenterology, 2014, (46) : 17483 - 17490
  • [6] A Comparative Analysis of Efficacy of Apatinib Combined with Transarterial Chemoembolization and Transarterial Chemoembolization Alone in the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
    Sun, Tao
    Chen, Lei
    Kan, Xuefeng
    Ren, Yanqiao
    Cao, Yanyan
    Zhang, Weihua
    Lu, Haohao
    Zheng, Chuansheng
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [7] Advanced Hepatocellular Carcinoma With Hepatic Arterioportal Shunts: Combination Treatment of Transarterial Chemoembolization With Apatinib
    Sun, Tao
    Ren, Yanqiao
    Kan, Xuefeng
    Chen, Lei
    Zhang, Weihua
    Yang, Fan
    Zheng, Chuansheng
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2020, 7
  • [8] Sorafenib combined with transarterial chemoembolization prolongs survival of patients with advanced hepatocellular carcinoma
    Liu, Quanguo
    Dai, Yajie
    JOURNAL OF BUON, 2020, 25 (02): : 945 - 951
  • [9] Transarterial chemoembolization combined with camrelizumab and apatinib in the treatment of advanced hepatocellular carcinoma: Preoperative or postoperative combination? A prospective clinical study
    Xie, Hui
    Yang, Yuqing
    Liu, Yane
    Wen, Zhenyu
    Wang, Junxiao
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Transarterial chemoembolization combined with sorafenib for advanced hepatocellular carcinoma
    Shao, Wenbo
    Zhang, Fengjuan
    Cong, Ning
    Li, Jinpeng
    Song, Jinlong
    ONCOLOGY LETTERS, 2014, 8 (05) : 2263 - 2266
12345